Application 208740
- Type
- ANDA
- Sponsor
- APOTEX INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE | TABLET;ORAL | 200MG;300MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 60505-4202 | Emtricitabine and Tenofovir Disoproxil Fumarate | emtricitabine and tenofovir disoproxil fumarate | Apotex Corp. | ANDA | Current |
| 60505-4202 | Emtricitabine and Tenofovir Disoproxil Fumarate | emtricitabine and tenofovir disoproxil fumarate | Apotex Corp. | ANDA | Current |